News

In a discovery that could broaden access to next-generation biologic medicines and vaccines, researchers at the University of ...
In a discovery that could broaden access to next-generation biologic medicines and vaccines, researchers at the University of ...
Cancer remains one of the leading causes of death worldwide, and despite advancements in diagnosis and treatment, it ...
The preclinical company’s lead asset uses lipid nanoparticles to deliver mRNA to liver cells that codes for transcription factors known to make hepatocytes look—and act—younger, NewLimit co ...